Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis
Background: Dimethyl fumarate (DMF) is an oral systemic agent approved for the treatment of moderate-to-severe psoriasis vulgaris. It has a favourable tolerability profile, but it is associated with a high incidence of mild and reversible adverse events. The aim of the article is to describe a clini...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioExcel Publishing Ltd
2021-05-01
|
| Colección: | Drugs in Context |
| Materias: | |
| Acceso en línea: | https://www.drugsincontext.com/dimethyl-fumarate-titration-for-the-systemic-treatment-of-moderate-to-severe-plaque-psoriasis |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|